You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
量子生物(300149.SZ):2019年淨利預降0%-25%
格隆匯 01-23 15:58

格隆匯1月23日丨量子生物(300149.SZ)披露2019年度業績預告,公司預計2019年1-12月歸屬於上市公司股東的淨利潤為約1.21億元–約1.61億元,同比下降0%至25%。業績變動原因如下:

1、本報告期內,醫藥研發服務及生產外包服務業務收入與淨利潤與上年同期相比保持穩定。

2、微生態營養及醫療業務於下半年恢復性增長,但受上半年微生態板塊收入下滑影響,本年微生態板塊營業收入較上年仍下降20%左右,微生態營養及醫療業務的淨利潤因受營收下降、醫療板塊的投入及上海睿智股權併購融資的財務費用增加等因素影響較上年同期下降幅度較大。

3、公司預計2019年非經常性利潤對淨利潤的影響金額為920萬元左右。

4、本報告期合併子公司上海睿智化學研究有限公司(“上海睿智”)全年經營成果,上年同期合併6-12月經營成果。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account